Publications by authors named "Genya Aharon-Hananel"

Claim this Profile
E
Effect of semaglutide add-on therapy for people living with type 1 diabetes and excess weight.
Noga C Minsky, Dmitriy Olshanskiy, Genya Aharon-Hananel

Diabetes Obes Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurodegeneration onset with glucagon-like peptide-1 receptor agonists in people with type 2 diabetes: a real-world multinational cohort study.
Meir Schechter, Alisa Fishkin, Ofri Mosenzon, Dvora R Sehtman-Shachar, Tali Cukierman-Yaffe, Genya Aharon-Hananel

Cardiovasc Diabetol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A national quality survey of in-patient diabetic foot care calls for centralizing care and improving patient communication.
Yaffa Ein-Gal, Genya Aharon-Hananel, Tal Sigawi, Omer Hamtzany, Itamar Raz

J Diabetes Complications· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality, kidney, and safety outcomes with SGLT2 inhibitors versus DPP4 inhibitors in patients with type 2 diabetes treated with systemic glucocorticoids: a real-world exploratory study.
Meir Schechter, Yovel Cohen, Alisa Fishkin, Ofri Mosenzon, Gil Leibowitz, Genya Aharon-Hananel

Diabetes Res Clin Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney Outcomes With Glucagon-Like Peptide-1 Receptor Agonists Versus Other Glucose-Lowering Agents in People With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Data.
Alisa Fishkin, Aliza Rozenberg, Meir Schechter, Dvora R Sehtman-Shachar, Genya Aharon-Hananel

Diabetes Metab Res Rev· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Representation of women in randomized controlled trials of novel antidiabetic drugs: A cohort study.
Genya Aharon-Hananel, Yovel Cohen, Noam Tau

Diabetes Obes Metab· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normoalbuminuria-is it normal? The association of urinary albumin within the 'normoalbuminuric' range with adverse cardiovascular and mortality outcomes: A systematic review and meta-analysis.
Dvora R Sehtman-Shachar, Ilan Yanuv, Meir Schechter, Alisa Fishkin, Genya Aharon-Hananel

Diabetes Obes Metab· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of Mankai plant consumption on postprandial glycaemic response among patients with type 2 diabetes: A randomized crossover trial.
Gal Tsaban, Genya Aharon-Hananel, Shiran Shalem, Hila Zelicha, Anat Yaskolka Meir

Diabetes Obes Metab· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycemic outcomes and patient satisfaction and self-management improves in transition from standard to virtual multidisciplinary care.
Noga Minsky, Liat Arnon Klug, Tatyana Kolobov, Elizabeth Tarshish, Yuval Shalev Many, Genya Aharon-Hananel

Diabetes Res Clin Pract· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between neonatal hypoglycaemia and cord blood C-peptide levels in neonates of birthing individuals with type 1 diabetes.
Genya Aharon-Hananel, Nimrod Dori-Dayan, Roni Zemet, Lihi Bakal, Amna Jabarin

Diabetes Metab Res Rev· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trabecular Bone Score Change Is Not Predicted by Bone Turnover: Short-term Sequential Follow-up.
Genya Aharon-Hananel, Galia Zacay, Noam Tau, Yael Levy-Shraga, Amit Tirosh

Isr Med Assoc J· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytochrome c Oxidase Activity as a Metabolic Regulator in Pancreatic Beta-Cells.
Genya Aharon-Hananel, Leonor Romero-Afrima, Ann Saada, Carmit Mantzur, Itamar Raz

Cells· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver findings in patients with Carney complex, germline PRKAR1A pathogenic variants, and link to cardiac myxomas.
Amit Tirosh, Ahmed Hamimi, Fabio Faucz, Genya Aharon-Hananel, Phaedon D Zavras

Endocr Relat Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anatomic site as prognostic marker of pancreatic neuroendocrine tumors: a cohort study.
Muhamad Badarna, Ruth Percik, Genya Aharon-Hananel, Inbal Uri, Amit Tirosh

Eur J Endocrinol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower all-cause mortality rates in patients harboring pituitary carcinoma following the introduction of temozolomide.
Genya Aharon-Hananel, Ruth Percik, Muhamad Badarna, Inbal Uri, Amit Tirosh

Endocrine· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes.
Marianna Yaron, Eytan Roitman, Genya Aharon-Hananel, Zohar Landau, Tali Ganz

Diabetes Care· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of the efficacy and safety of Tofogliflozin for the treatment of type II diabetes.
Genya Aharon-Hananel, Itamar Raz

Expert Opin Pharmacother· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological presentation of cardiac mitochondria in a rat model for chronic kidney disease.
Einat Bigelman, Lena Cohen, Genya Aharon-Hananel, Ran Levy, Zach Rozenbaum

PLoS One· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous subcutaneous insulin infusion-an opportunity for better care but not a "magic pill".
Avivit Cahn, Eytan Roitman, Genya Aharon-Hananel, Itamar Raz

Endocrine· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidiabetic Effect of Interleukin-1β Antibody Therapy Through β-Cell Protection in the Cohen Diabetes-Sensitive Rat.
Genya Aharon-Hananel, Anne Jörns, Sigurd Lenzen, Itamar Raz, Sarah Weksler-Zangen

Diabetes· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-1β hampers glucose-stimulated insulin secretion in Cohen diabetic rat islets through mitochondrial cytochrome c oxidase inhibition by nitric oxide.
Sarah Weksler-Zangen, Genya Aharon-Hananel, Carmit Mantzur, Tzemach Aouizerat, Ewa Gurgul-Convey

Am J Physiol Endocrinol Metab· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary copper supplementation restores β-cell function of Cohen diabetic rats: a link between mitochondrial function and glucose-stimulated insulin secretion.
Sarah Weksler-Zangen, Anne Jörns, Limor Tarsi-Chen, Fiona Vernea, Genya Aharon-Hananel

Am J Physiol Endocrinol Metab· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis